表紙
市場調查報告書
商品編碼
1019410

全球微載體市場:增長、趨勢、COVID-19 影響、預測(2021-2026)

Microcarrier Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 113 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

微載體市場的規模主要是由於對基於細胞的疫苗和療法的需求不斷增長、生物製藥和生物仿製藥行業的快速增長、增加的研發以及細胞療法研究的資金。可用性等因素。

目前在研的許多生物製藥都針對小分子占主導地位且患者群體龐大的適應症。這表明,在預測期內,生物製藥趨勢可能會落入生物疾病的一些非傳統領域,並可能受益於治療效果的提高。此外,這為生物仿製藥市場提供了增長空間。

生物製藥在醫療福利、廣泛治療和人口獲取方面具有巨大潛力,其中許多尚未開發。隨著基於微載體的合成等製造技術的進步,這種潛力逐漸實現,從而導致更有效治療的商業化、製造效率的提高和治療成本的降低。因此,生物製藥和生物類似藥行業的快速增長將對市場產生積極影響。

本報告調查了全球微載體市場,概述了市場,分析了市場增長和障礙、市場機遇、COVID-19 的影響以及按材料類型、應用和地區劃分的市場規模趨勢。它提供了系統信息,例如預測、競爭條件和主要公司的簡介。

目錄

第 1 章介紹

第二章調查方法

第 3 章執行摘要

第 4 章市場動態

  • 市場概覽
  • 市場驅動力
    • 對基於細胞的疫苗和療法的需求不斷增加
    • 生物製藥和生物類似藥行業快速增長
    • 細胞療法研究的研發和資金供應增加
  • 市場限制
    • 生物製藥和細胞療法的高成本
    • 高密度微載體培養的生長極限
  • 波特五力分析

第 5 章市場細分

  • 按材料類型
    • 藻酸鹽鹼
    • 膠原蛋白基礎
    • 葡聚醣基
    • 聚苯乙烯基
    • 其他
  • 按應用程序
    • 細胞療法
    • 疫苗製造
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美洲

第6章競爭形勢

  • 公司簡介
    • Danaher Corporation
    • Eppendorf AG
    • GE Healthcare
    • Lonza Group AG
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Sartorius AG

第7章 市場機會動向

目錄
Product Code: 64708

The microcarrier market is majorly driven by factors such as rising demand for cell-based vaccines and therapeutics, the rapid growth of biologics and biosimilar industry, and increasing R&D and availability of funding for cell therapy research.

Many of the current biologics in the pipeline are targeting the indications, which are small-molecule dominated and have a large patient pool. This represents that in the forecast period the trend of biologics could enter several of the non-traditional biologic disease areas, which could benefit from the increased therapeutic efficacy. Furthermore, this is also providing the room to the biosimilar market to grow.

In terms of medical efficacy, therapeutic spread, and population access biopharmaceuticals have vast potential, and much of this potential is still untapped. This potential can gradually be realized as manufacturing technologies, such as microcarrier based synthesis make progress, which may lead to commercialization of more effective therapies, increased manufacturing efficacy, and reduced therapy costs. Hence, owing to such rapid growth of the biologics and biosimilar industry, the market is positively affected.

Key Market Trends

Cell Therapy is Expected to Show Fastest Growth by Application, Over the Forecast Period

Microcarriers help in cost-effective cell production i.e they contribute to reducing fixed as well as variable costs during the large scale manufacturing. With technological advancements, the current scenario has changed and the significance of microcarriers in cell therapy has increased. For instance, dissolvable microcarriers are currently there in the market that is composed of cross-linked polysaccharide polymers that can be efficiently dissolved during the cell harvest step. As the microcarriers get completely dissolved, there is no need for the separation and simply, the downstream process goes well. Therefore, these microcarriers are considered as beneficial beads for large scale cell production or cell therapy application.

Along with the above-mentioned statements, another factor that is responsible for the growth of cell therapy applications of microcarriers is that companies are currently focusing on the provision of microcarriers that contribute to the large scale and cost-effective production. For example Corning Incorporated provides dissolvable microcarriers. These factors boost the growth in cell therapy applications.

North America is Expected to Dominate the Market Over the Forecast Period

North America region is believed to have the largest share in the microcarrier market. This is majorly due to the rising gene and cell therapy research in the region along with the associations that are supporting this research. For instance, the American Society of Gene and Cell Therapy is responsible for the funding of the research and also, this society is forcing the biopharmaceutical and biotech companies to improve their R&D.

Along with that, the United States is witnessing high and rapid growth in the biologics and biosimilar Industry which is one of the major factors driving the microcarrier market in this region.

Competitive Landscape

The Microcarrier market is mostly inclusive of the global players and few companies that are currently dominating the market include Thermo Fisher Scientific, Sartorius AG, Eppendorf AG, Danaher Corporation (Pall Corporation), and Merck KGaA. The competition in the market is expected to increase as new companies are also coming up in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition​
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Cell-based Vaccines and Therapeutics
    • 4.2.2 Rapid Growth of Biologics and Biosimilar Industry
    • 4.2.3 Increasing R&D and Availability of Funding for Cell Therapy Research
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Biologics and Cell-based Therapies
    • 4.3.2 Possible Drawbacks of Microcarrier Cultures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Material Type
    • 5.1.1 Alginate-Based
    • 5.1.2 Collagen-Based
    • 5.1.3 Dextran-Based
    • 5.1.4 Polystyrene-Based
    • 5.1.5 Others
  • 5.2 By Application
    • 5.2.1 Cell Therapy
    • 5.2.2 Vaccine Manufacturing
    • 5.2.3 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Danaher Corporation
    • 6.1.2 Eppendorf AG
    • 6.1.3 VWR International LLC
    • 6.1.4 Lonza Group Ltd
    • 6.1.5 Merck KGaA
    • 6.1.6 Thermo Fisher Scientific Inc.
    • 6.1.7 Sartorius AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS